Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride doesn't affect bone density in male rats.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Finasteride doesn't affect bone density in male rats.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

About 15% of adolescent girls in a region of India have Polycystic Ovarian Syndrome, which is more common in those born by cesarean, with wisdom teeth, or with central obesity.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

ChatGPT-5 can pass the endocrinology exam but isn't fully reliable for clinical decisions yet.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

A holistic approach, including lifestyle changes and surgery, is recommended for better long-term PCOS management.